SS
Sangramsinh Sharad
About Sangramsinh Sharad
Data last updated:
Sangramsinh Sharad is a Director at Balaji Medivision Private Limited (since 2022) and Director at Balaji Vetgen Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹81.81 Cr; the largest is Balaji Medivision Private Limited at ₹75.18 Cr (FY 2025). Earlier, Sangramsinh Sharad was a Director at Pharmacon Medisales Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Balaji Medivision Private Limited U24299PN2021PTC199510 | Director | 22 Nov 2022 | 2021 | ₹75.18 Cr (FY 2025) | Active |
| Balaji Vetgen Private Limited U33119PN2022PTC207437 | Director | 22 Feb 2023 | 2022 | ₹6.63 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Pharmacon Medisales Private Limited U52311PN2013PTC149189 | Director | 21 Oct 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sangramsinh Sharad
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangramsinh Sharad
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangramsinh Sharad
Sangramsinh Sharad currently holds 2 directorships: Balaji Medivision Private Limited (Director, since 22 Nov 2022, revenue ₹75.18 Cr (FY 2025)); Balaji Vetgen Private Limited (Director, since 22 Feb 2023, revenue ₹6.63 Cr (FY 2024)).
Sangramsinh Sharad was first appointed on 21 Oct 2013 as Director at Pharmacon Medisales Private Limited. The most recent appointment on record is 22 Feb 2023 at Balaji Vetgen Private Limited.
The 2 current companies of Sangramsinh Sharad that report revenue have a combined latest revenue of ₹81.81 Cr: Balaji Medivision Private Limited ₹75.18 Cr (FY 2025); Balaji Vetgen Private Limited ₹6.63 Cr (FY 2024).
Sangramsinh Sharad held 1 earlier board appointment: Pharmacon Medisales Private Limited (Director, from 21 Oct 2013).
The current boards of Sangramsinh Sharad's companies include Ajay Sayaji Alavekar (Balaji Medivision Private Limited), Amarnath Madan Patil (Balaji Medivision Private Limited), Anil Babanrao Mhapsekar (Balaji Medivision Private Limited), Arvind Pandurang Khade (Balaji Medivision Private Limited), Dadasaheb Yashavant Deshmukh (Balaji Medivision Private Limited), Dhairyashil Suyash Pawar (Balaji Medivision Private Limited), among others.